Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease.
Cong Xiang ShaoJunzhao YeZhi DongFuxi LiYansong LinBing LiaoShiting FengBi-Hui ZhongPublished in: Therapeutic advances in chronic disease (2021)
CAP has decreased value for the initial screening of moderate-severe steatosis and is limited in monitoring changes in steatosis during treatment. The confirmation of steatosis grading with MRI-PDFF remains necessary.